• Is 70Zn(d,x)67Cu the Best Way to Produce 67Cu for Medical Applications?, Nigron, E.; Guertin, A.; Haddad, F.; Sounalet, T., Front. Med. 2021, 8, 674617. doi:10.3389/fmed.2021.674617

  • Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy, Radchenko, V.; Morgenstern, A.; Jalilian, A. R.; Ramogida, C. F.; Cutler, C.; Duchemin, C.; Hoehr, C.; Haddad, F.; Bruchertseifer, F.; Gausemel, H.; Yang, H.; Osso, J. A.; Washiyama, K.; Czerwinski, K.; Leufgen, K.; Pruszyński, M.; Valzdorf, O.; Causey, P.; Schaffer, P.; Perron, R.; Maxim, S.; Wilbur, D. S.; Stora, T.; Li, Y., J Nucl Med 2021, 62 (11), 1495–1503. doi:10.2967/jnumed.120.261016

  • Bremsstrahlung X-rays as a non-invasive tool for ion beam monitoring, Ralite F, Koumeir C, Guertin A, Haddad F, Mouchard Q, Servagent N, et al.. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. août 2021;500‑501:76‑82.doi:10.1016/j.nimb.2021.05.013

     

  • Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements, Mikolajczak R, Huclier-Markai S, Alliot C, Haddad F, Szikra D, Forgacs V et al., EJNMMI radiopharm chem. déc 2021;6(1):19.
    https://doi.org/10.1186/s41181-021-00131-2
  • New results on proton-induced reactions on vanadium for 47Sc production and the impact of level densities on theoretical cross sections, Barbaro, F. and Canton, L. and Carante, M. P. and Colombi, A. and De Dominicis, L. and Fontana, A. and Haddad, F. and Mou, L. and Pupillo, G., Phys. Rev. C, 25 oct 2021;104:044619. 10.1103/PhysRevC.104.044619

  • Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development, Gadelshin VM, Formento Cavaier R, Haddad F, Heinke R, Stora T, Studer D, et al., Front Med. 12 oct 2021;8:727557. https://doi.org/10.3389/fmed.2021.727557

  • Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”, Eychenne R, Chérel M, Haddad F, Guérard F, Gestin J-F., Pharmaceutics. 18 juin 2021;13(6):906. https://doi.org/10.3390/pharmaceutics13060906